Ignite Creation Date:
2025-12-24 @ 10:00 PM
Ignite Modification Date:
2026-02-25 @ 5:52 PM
Study NCT ID:
NCT00531232
Status:
COMPLETED
Last Update Posted:
2022-03-24
First Post:
2007-09-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Dose Confirmation Study of Oral Clofarabine for Adult Patients Previously Treated for Myelodysplastic Syndromes (MDS)
Sponsor:
Genzyme, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-05-07
Start Date Type:
ACTUAL
Primary Completion Date:
2011-05-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-05-12
Completion Date Type:
ACTUAL
First Submit Date:
2007-09-14
First Submit QC Date:
None
Study First Post Date:
2007-09-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-10-04
Results First Submit QC Date:
None
Results First Post Date:
2021-11-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-12-22
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2022-03-15
Last Update Post Date:
2022-03-24
Last Update Post Date Type:
ACTUAL